Short Term Rating on Agilent Technologies (A)

Agilent Technologies (A) has an average broker rating of 1.8, which is interpreted as a Buy, as rated by 10 equity analysts. Nonetheless, 6 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 4 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 2, which is also a Buy.

Agilent Technologies (A) : 8 Wall Street analysts covering Agilent Technologies (A) believe that the average level the stock could reach for the short term is $49.38. The maximum price target given is $55 and the minimum target for short term is around $45, hence the standard deviation is calculated at $3.02.

For the current week, the company shares have a recommendation consensus of Buy.


Agilent Technologies (NYSE:A): During Tuesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $45.77 and $45.64 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $46.66. The buying momentum continued till the end and the stock did not give up its gains. It closed at $46.53, notching a gain of 2.49% for the day. The total traded volume was 2,237,748 . The stock had closed at $45.40 on the previous day.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.